Find an expert

Dr Trzaskowski is Head of Research at Max Kelsen, providing supervision to 10 researchers and machine learning engineers, as well as 3 PhD students and 2 postdocs. He also holds a position of a visiting scientist at QIMR Berghofer Medical Research Institute and is an Associate Investigator at the ARC Centre of Excellence for Information Resilience (The University of Queensland) as well as the ARC Centre of Excellence for Automated Decision-Making and Society. He previously held the title of The British Academy Fellow aiming to improve utilisation of polygenic risk prediction in large population samples. He also underwent extensive training in a variety of Artificial Intelligence techniques such as Machine Learning and Multi-Agent Systems, with a specific focus on Agent Based Modelling, at University of Washington, Seattle, as well, as at the Department of Mathematics and Engineering, King's College London.

Dr. Wei-An (Vivien) Tsai graduated with a Bachelor of Science in the Department of Plant Pathology and Microbiology, as well as a Master of Science from the Institute of Plant Biology at National Taiwan University in Taiwan. In 2023, she completed her doctoral studies at the Queensland Alliance for Agriculture and Food Innovation (QAAFI), The University of Queensland. Her research during PhD studies aimed to uncover the involvement of small RNA in plant-capsicum chlorosis virus pathosystem under climate change scenarios of elevated temperatures. Additionally, she explored the potential of using RNA-based techniques for managing CaCV. Before joining QAAFI, Wei-An worked at the Hualien District Agricultural Research and Extension Station, Ministry of Agriculture in Taiwan. During this period, her research interests centred around plant-induced resistance to viruses and the selection and fermentation of antagonistic bacteria. Post-PhD, Wei-An joined the Mitter group as a postdoctoral researcher for the Australia-India Strategic Research Fund project. Her current focus lies in topical applications of dsRNA or other RNA-based techniques for targeting whitefly and whitefly-transmitted viruses including tomato yellow leaf curl virus.

Dr Ben Tscharke is an analytical chemist with a keen interest in quantifying analytes in environmental samples. Ben is currently a Senior Research Fellow at the University of Queensland research institute, Queensland Alliance for Environmental Health Sciences (QAEHS), joining in February 2017 after graduating his PhD from the University of South Australia the previous year. His key focus at QAEHS involves the wastewater based epidemiological approach to determine community consumption and exposure to a range of illicit drugs, pharmaceuticals and personal care products. He leads the Australian Criminal Intelligence Commission's National Wastewater Drug Monitoring program at UQ, which collaborates with the University of South Australia (https://www.acic.gov.au/publications/intelligence-products/national-wastewater-drug-monitoring-program-report).

Elinor Tsen is a Postdoctoral Research Fellow at the School of Electrical Engineering and Computer Science.

Elinor's research interests relate to the adoption and development of mature cyber security and resilience practices within organisations.

Professor Kylie Tucker leads a positive research environment, where exceptional basic science and clinical researchers come together to advance knowledge about muscles and movement control. Her work has transformed our understanding of how pain impacts movement; showcased methods for estimating muscle forces; and advanced the assessment of childhood movement control and adolescent skeletal maturity. Recently, Kylie has drawn on her fundamental science knowledge to propose a shift in our understanding of the potential drivers of scoliosis progression. Approximately one child in every Australian classroom, and 3-7% world-wide, will develop adolescent idiopathic scoliosis. There is no known cause, nor strong evidence to determine when or where to target non-invasive treatment. Each year in Queensland >200 adolescents have up to 12 vertebrae fused as conservative treatment has not stopped their curve progression. Her group have identified unique, targetable muscle features, that can be non-invasively detected early in curve progression.

In parallel to her research, Kylie teaches about muscles and movement control across 10 UQ programs, where class size ranges from 70-1400 students. Within the School of Biomedical Science she was the Deputy Director Teaching and Learning (2018-20), the inaugural chair of the people centred, REMEDE committee (2021-23); and Director of Teaching and Learning (2024-3/25). Kylie co-facilitates UQ’s flagship Career Progression for Women program (2024- ), and intentionally fosters a supportive academic culture, empowering academics in their pursuit of excellence, across all her roles. She is the current (2024-26) President of the International Society of Electrophysiology and Kinesiology (ISEK); a global organization composed of 375 members in health-related and basic science fields with a common desire to study human movement and the neuromuscular system. Kylie has contributed to the leadership of this society since 2018.

Karen Tuesley is an early career researcher and Lecturer in epidemiology at the School of Public Health, University of Queensland. Karen’s research focuses on women’s health and cancer epidemiology using large longitudinal datasets. Her PhD research used large-scale data to explore the associations between the use of chronic disease medications and the risk of ovarian cancer. She also researches long-term health outcomes for women after gynaecological surgery. Karen works with large observational studies with longitudinal data and is experienced with different analytic techniques and methods including emulated trials and Mendelian randomisation.

I am the lead of the Effective and Efficient Healthcare program at the Centre for the Business and Economics of Health at The University of Queensland. I also lead Health Technology Assessment for the Centre, which involves evaluating submissions made to the Australian Government to reimburse new medicines and medical devices through the Pharmaceutical benefits Scheme (PBS) and the Medicare Benefits Schedule (MBS). My research is focused on the economic evaluation of health interventions to inform decision making and promote value-based health care. I have pioneered the application of Value of Information (Research) analysis to enhance the efficiency of clinical trials and maximise the return on investment from medical research.

I have extensive experience working with key stakeholders including consumers, clinicians, decision makers and researchers. I am chief investigator on over $45 million Category 1 grants from the NHMRC, MRFF and ARC. In addition, I lead several projects for the Department of Health and other peak organisations.

I chair the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Oncology GroupI, and I am the past chair of the Clinical Oncology Society of Australia's (COSA)-Epidemiology Group and the Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group. I am an Associate Editor for Value in Health, and an Editorial Board Member for Medical Decision Making and PharmacoEconomics-open journals.

John-Paul Tung is a Senior Research Fellow at Australian Red Cross Lifeblood (Lifeblood). He leads a program of research focused on the changes that occur in blood in between collection and transfusion, as well as how these changes might impact transfused patients. Particular focuses are on transfusion-related acute lung inujry (TRALI), transfusion-associated circulatory overload (TACO), and extracellular vesicles. He leads a research team of five Senior Research Assistants and three Research Assistants. He also supervises several PhD and Masters students. He holds an Honorary Senior Research Fellow position with the Faculty of Medicine at UQ. He also holds an adjunct Associate Professor position with the University of the Sunshine Coast and an adjunct Senior Lecturer position with QUT. He is also a former Secretary and Council Member of the International Society of Blood Transfusion's Young Professionals Council.

John-Paul completed a Bachelor of Science at UQ in 1999, after which he worked as a Scientist in nucleic acid testing in Brisbane, Melbourne and London. After returning to Brisbane, he commenced work as a Research Scientist with Lifeblood (formerly the Blood Service) in 2007. John-Paul then commenced a PhD with UQ and Prince Charles Hospital's Critical Care Research Group in 2008. His PhD, conferred in 2012, invovled the development of the first large animal model of TRALI using sheep, and resulted in several awards including best paper prizes from the International Society of Blood Transfusion and the Prince Charles Hospital as well as other awards from the Australian and New Zealand Society of Blood Transfusion and the British Blood Transfusion Society.

Dr. Kelvin Tuong is a Senior Research Fellow/Group Leader at the Ian Frazer Centre for Children’s Immunotherapy Research (IFCCIR), Child Health Research Centre. He is interested in single-cell analysis of immune cells and harnessing adaptive immune receptors for understanding immune cell development and function in health and in cancer.

Dr. Tuong was born and raised in Singapore and moved to Brisbane, Australia, after completing national service in Singapore and obtaining a Diploma in Biomedical Laboratory Technology (Ngee Ann Polytechnic).

Dr. Tuong was originally trained as a molecular cell biologist and gradually transitioned into bioinformatics during his post-doctoral training. He has been very prolific for an early career researcher, having published >70 articles since 2013, with nearly a third of them as first/co-first or last author and has a stellar track record of pushing out highly collaborative work in prestigious journals including Nature, Cell, Science, Nature Medicine, Nature Biotechnology J Exp Med etc. He has the rare combination of having excellent laboratory and bioinformatics skill sets which provide him a strong command of both fundamental immunology and computational approaches.

Dr. Tuong completed his undergraduate Bachelor's degree in Biomedical science with Class I Honours, followed by his PhD in macrophage cell biology and endocrinology at UQ (Prof. Jenny Stow lab and Emiritus Prof. George Muscat lab, IMB, UQ). He then went on to a post-doc position with Emiritus Prof. Ian Frazer (co-inventor of the Gardasil cervical cancer vaccine, UQ Frazer Institute, Translational Research Institute) where he worked on HPV immunology, cervical cancer and skin cancer. In his time in the Frazer lab, he developed an interest in bioinformatics analyses as a means to tackle and understanding immunology problems in health and disease. He then moved to the UK and joined Prof. Menna Clatworthy's lab at the University of Cambridge and Dr. Sarah Teichmann's lab at the Wellcome Trust Sanger Institute. He has focused his interests on single-cell analyses of tissue immune cells, including T and B cells and their specific receptors (TCR/BCR). He has developed bespoke bioinformatics software, including one tailored for single-cell B Cell Receptor sequencing analysis, Dandelion, which he used in one of the largest combined single-cell transcriptomic, surface proteomic and TCR/BCR sequencing dataset in the world, published in Nature Medicine, and more recently in Nature Biotechnology where we introduced a TCR-based pseudotime trajectory analysis method.

Dr. Tuong is now leading the Computational Immunology group at the IFCCIR and his lab is focused on investigating how pediatric immunity is perturbed during cancer at the cellular level and how this information can be used for creating novel warning systems for children with cancer. For potential students/post-docs/trainees interested in joining the team, please contact Dr. Tuong at z.tuong@uq.edu.au.

Karnaker's research interests are natural products, peptide-based drug discovery and development, formulation chemistry and non-viral gene delivery system. Karnaker co-inventor and developed a novel, bioresponsive disulphide-linker technology, which has been used for non-viral vectors, peptide-therapeutics for pain and cancer treatment. Karnaker is also keen interest for topical, mucosal drug delivery using a range of dendrimer, nano and microbubbles, lipid and polymer-based nanoparticle systems in conjugation with both biological and physical stimuli-responsiveness.

Karnaker received a PhD in Pharmaceutical Chemistry from The University Queensland under the supervision of Dr Harendra Parekh and Dr Defang Ouyang. Prior to PhD, he completed a Master degree in Pharmaceutical Analysis and Quality assurance (India). Also worked as analytical research and development chemist for one year in a Pharma company. Since 2016, he his working with Dr Parekh team on a range of Industry-funded research projects and his role involves from ideation, research plan, execution, product delivery to industry partners on major platforms such as peptide-based therapeutics, gene therapy and sol-gel technology.

Dr Michael Turner

Senior Lecturer in Accounting

Program Convenor, Bachelor of Advanced Business (Honours)

Dr Michael J. Turner is a Senior Lecturer in Accounting and Program Convenor for the Bachelor of Advanced Business (Honours) at The University of Queensland Business School. He holds a PhD in Accounting, a Bachelor of Business (First Class Honours) and a Graduate Certificate in Research Management.

Michael’s scholarship explains how decision‑oriented accounting information—and the management controls that create and communicate it—influence strategic, ethical and climate‑related choices across diverse organisations. He has authored 30‑plus peer‑reviewed articles (5 A★, 19 A ABDC; two FT 50), attracting 437 Scopus citations and an h‑index of 12 (as at June 2025). His projects have been funded by Chartered Accountants Australia & New Zealand, the German Research Foundation and the Australian Accounting Standards Board, and practitioner outlets such as Strategic Finance, HospitalityNet and the Council on Business & Society have featured his applied insights.

Research interests

• Strategic management accounting & analytics – capital budgeting, cost systems, competitor intelligence, AI pricing

• Corporate & climate‑related disclosure – economic consequences of ESG reporting

• Ethical decision‑making & governance – whistle‑blowing incentives, fraud deterrence

• Accounting education & technology – data‑analytics pedagogy with Python and R

A unifying question threads these streams together: How can accounting systems create and communicate information that drives smarter and more responsible business decisions?

Teaching & Program Leadership

Teaching. Michael coordinates management‑accounting courses that consistently receive outstanding teacher ratings in the mid‑ to high‑4s out of 5 . His Python‑ and R‑based cases have won international awards and are adopted worldwide.

Program leadership. As Program Convenor he applies a business‑analyst mindset—interrogating enrolment trends, assessment data and employer feedback—to steer evidence‑based improvements in curriculum design, assessment integrity and student experience.

Engagement & Service – Program Convenor spotlight

• Academic Program Review Lead (2023 – mid 2025).

  • Directed the first comprehensive review of UQ’s flagship Bachelor of Advanced Business (Honours) since its 2018 launch, coordinating faculty, students, alumni and external reviewers.

  • Delivered a data‑rich report mapping enrolment patterns, graduate outcomes and financial sustainability, and set a strategic agenda for work‑integrated learning, first‑year cohort building and program distinctiveness.

• Implementation Plan Leader (mid 2025 – mid 2028).

  • Leading cross‑disciplinary teams to design cohort‑specific advanced courses and new industry‑embedded learning experiences.

  • Monitoring key performance indicators—retention, satisfaction, graduate destinations—so that curricular changes translate into measurable impact.

• Continuous quality assurance.

  • Conducts targeted course audits to recalibrate marking guides, assessment weightings and learning resources, and mentors coordinators through change processes.

Karen Turner is a clinical psychologist and research academic. She is Deputy Director at the Parenting and Family Support Centre. Her research activity focuses on the impact of evidence-based parenting support on child, family and community outcomes. She is a foundational co-author of the Triple P – Positive Parenting Program and has published more than 50 professional manuals, parent workbooks, tip sheet series, and video programs, which are currently being used in 27 countries, in 20 languages. She has also co-written television segments and four interactive online parenting programs. She has clinical and research experience relating to parent wellbeing, child development, and the prevention and treatment of a variety of childhood behavioural and emotional problems, including work with feeding disorders, pain syndromes and conduct problems. Her research has also focused on the development and evaluation of brief primary care interventions in the prevention of behaviour disorders in children, and the dissemination of these interventions to the professional community. She has also conducted series of research into: online delivery of parenting programs; the cultural tailoring of mainstream parenting programs for Indigenous families; and enhancing the training and post-training environment for Indigenous professionals. Her current work includes further resource development for primary care settings, early education settings, and an ongoing focus on making evidence-based parenting support programs more accessible for First Nations families, and in low-resource and developing communities.

Associate Professor Ryan Turner is the Director of the Reef Catchments Science Partnership at the University of Queensland (a partnership with the Department of the Environment, Tourism, Science and Innovation). Ryan was previously the Department's Principal Scientist for Water Quality and Investigations and held an Adjunct Associate Professor role at Queensland University of Technology in the Managing for Resilient Landscapes, Institute for Future Environments. For 14 years, Ryan managed multimillion-dollar water quality monitoring programs assessing the impacts of sediments, nutrients, and pesticides in numerous catchments along the Queensland coast discharging to the Great Barrier Reef and Moreton Bay. Ryan has been on several steering committees and technical advisory panels, such as the Great Barrier Reef Foundations Technical Advisory Panel. He has published extensively (>80 papers and reports) and led several Queensland Government – Academic collaborative research projects. Ryan previously supervised analytical chemistry and microbiology laboratories in the private and public sectors. Ryan has developed numerous methodologies and standard operating procedures for analytical and monitoring techniques (water quality, sediments and soils). Ryan’s passion for the future of water security is what keeps him striving forward.

Dr Joseph Turner works clinically as a GP Obstetrician/Rural Generalist, having received his primary medical degree at the University of Queensland. He completed his PhD in Pharmacy at the University of Sydney. His current reseach interests include women's and reproductive health, restorative reproductive medicine, and fertility awareness based methods of family planning.

He has a particular focus on progesterone-after-mifepristone (PAM) for women who have changed their mind after commencing a medical abortion and who wish instead to keep their pregnancy. Some of these women seek to undertake what is colloquially known as "abortion reversal." Dr Turner conducted the second only clinical trial in this field (the PAMper study) and is collaborating internationally with further research into abortion reversal. His research is clinically-oriented, aiming to provide high quality quantitative and qualitative data in order to assist women facing difficult abortion decisions. He has authored a number of key publications in the field of abortion reversal and is one of the leading international experts in the field.

Graeme Turner is one of the founding figures in media and cultural studies in Australia, and a leading figure internationally. He has published 23 books with international publishers, his work has been translated into 9 languages, and many of his books have gone into multiple editions. A former ARC Federation Fellow, a past President of the Australian Academy of the Humanities and the founding Director of the Centre for Critical and Cultural Studies (2000-2012), his most recent projects have been focused on television and new media, and the formation of national communities. His most recent publications include (with Anna Cristina Pertierra) Locating Television: Zones of Consumption (Routledge, 2013), What's Become of Cultural Studies? (Sage, 2012), Ordinary People and the Media: The Demotic Turn (S(Sage, 2010), and (with Jinna Tay) Television Studies after TV: Understanding television in the post-broadcast era (Routledge, 2009). He is an Emeritus Professor in the Centre for Critical and Cultural Studies..

Mark is a Professor of food microbiology and serves as a Deputy Head of the School of Agriculture and Food Sustainability (since 2019) and as the current Head of the Food Science & Technology Discipline in the school. He is also a Deputy Lead of the Innovative Ingredients program at the Food and Beverage Accelerator (FaBA), funded by the Australian Trailblazer university program scheme. He leads a research team focused on food safety, quality, and fermentation. After completing his PhD at Queensland University of Technology (QUT) under Prof Phil Giffard's supervision, he underwent postdoctoral training in Prof John Helmann's laboratory at Cornell University, USA (1999-2000), and at the CRC for Diagnostic Technologies, QUT (2000-01). He subsequently supported his position through a Dairy Australia Fellowship (2001-03) and an NHMRC New Investigator Grant (2004-06). In 2007, he joined UQ as an academic specialising in food microbiology.

Mark's research is currently funded by Hort Innovation, and he has received past funding from ARC Discovery, ARC Linkage, ARC Industrial Transformation Research Hub and ARC Industry Transformation Training Centre schemes. He has also been supported by Agrifutures Australia, Dairy Innovation Australia Ltd (DIAL), and the Geoffrey Gardiner Dairy Foundation (GGDF). His research primarily focuses on foodborne pathogen source tracking using WGS, lactic acid bacteria applications, plant-based dairy alternative fermentations, beer fermentation microbiology, precision fermentation and biocontrol food applications targeting pathogens like Campylobacter and Listeria monocytogenes. He has successfully supervised 20 PhD and MPhil students to completion and currently supervises 3 postdoctoral research fellows and 2 PhD students.

Mark was the Director of the Master of Food Science & Technology program from 2008-2018. He contributes to teaching in food microbiology, food safety, and food biotechnology subjects at UQ. He is a Fellow of both the Australian Society for Microbiology (FASM) and the Australian Institute of Food Science and Technology (FAIFST), and serves on the editorial boards the Journal of Food Protection and Food Australia. He was the recipient of the 2017 Keith Farrer Award of Merit and the 2023 President's Award from the Australian Institute of Food Science and Technology (AIFST) for service to the food industry and the Institute. Additionally, Mark currently holds the position of President and Affiliate Council Delegate of the Australian Association for Food Protection (AAFP), the affiliate of the International Association for Food Protection (IAFP).

Dr Turni leads a national and international reference laboratory for respiratory bacterial pathogens where identification, serotyping, genotyping, sequencing and antimicrobial sensitivity testing is performed. Her team works with the poultry, pig and cattle industries, as well as major veterinary pharmaceutical companies around the world. The group performs vaccine efficacy trials, provides advice on vaccine strain selection, performs antimicrobial sensitivity testing and evaluates candidate novel antimicrobial agents. Essentially, the services provided by the group underpins the entire Australian prevention and control programs for the major bacterial respiratory diseases of pigs, poultry and cattle.

Her research has extended beyond vaccines and antibiotic sensitivity to determining optimal sample sites for collecting pathogens, understanding the association of different pathogens with disease, development of animal infection models, classification of bacteria and epidemiology of pathogens. Conny supervises PhD students with diverse projects such as antimicrobial sensitivity studies, risk factors and profiling of pathogenic Escherichia coli associated with avian collibacillosis, alternatives to antibiotics, development of on farm test for a virus and study of epidemiology of a new species of bacteria. She works in collaboration with a team of epidemiologist, veterinarian and virologist on projects in Australia and overseas.

Dr Turpin’s research centres on the clinical/professional reasoning of occupational therapists across the spectrum of experience from new graduates to experts, as well as the subjective experiences of people with disabilities. She specialises in the use of qualitative research methods and uses a variety of qualitative research methods in her own research, as well advising others on these research methods. Dr Turpin has written books and book chapters on occupational therapy models of practice, evidence-based practice, and clinical reasoning, as well as publications on various aspects of people's experience. Dr Turpin has been a teaching and research academic at The University of Queensland for more than 30 years. The connection between theory and practice is central to her research and teaching. As occupational therapists attend to both thinking and experience, they need to use rigorous thinking and a deep understanding of human experience in their practice.